Brain zapping trial maps current paths in epilepsy patients

NCT ID NCT02263274

Completed Knowledge-focused Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study used 30 epilepsy patients who already had electrodes implanted in their brains for surgery planning. Researchers applied a mild electrical stimulation called tDCS and measured exactly how the current spread. The goal was to improve computer models that predict where the electricity goes, which could help design better brain stimulation treatments in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Transcranial Direct Current Stimulation (tDCS)
What this could lead to: If successful, this could lead to more precise tDCS targeting for brain stimulation therapies in conditions like depression or epilepsy.
What could go wrong: This is a small, early-stage measurement study, not a treatment trial. The stimulation levels are very low and not expected to change brain function, so direct patient benefits are unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPILEPSY

Contacts and locations

Locations

Neurology

New York, New York, 11106, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.